Drug Class or Subclass
Generic
Ubrogepant
Brand Name
Ubrelvy
| Interaction Color Code | Clinical Bottom Line | Clinical Effects | Drug 1 effect | Drug 2 dose | Drug 2 effect | Management | |
|---|---|---|---|---|---|---|---|
| Lenacapavir Ubrogepant | Yellow: Adjust dosing | Minimal data to guide interaction: weigh risks and benefits of using this combination | Potential increased risk of ubrogepant adverse effects |
If coadministering, avoid taking a second dose of ubrogepant within 24 hours |